Symptomatic Progression-Free Survival: New Myeloma Measure
In a groundbreaking development for the treatment and evaluation of multiple myeloma (MM), a novel patient-centered endpoint called symptomatic progression-free...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking development for the treatment and evaluation of multiple myeloma (MM), a novel patient-centered endpoint called symptomatic progression-free...
In the ever-evolving landscape of oncology, metastatic gastric cancer remains one of the most formidable challenges clinicians face today. This...
In a groundbreaking study poised to reshape the understanding of breast cancer therapeutics, researchers have unveiled compelling evidence showcasing the...
In the relentless battle against hepatocellular carcinoma (HCC), a groundbreaking study has uncovered critical epigenetic mechanisms that regulate immune cell...
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as...
City of Hope is at the forefront of biomedical innovation, unveiling a series of pioneering clinical investigations and scientific breakthroughs...
In a striking analysis spanning two decades, new research has shed light on the shifting landscape of liver cancer incidence...
In a landmark study poised to redefine the approach to staging colon cancer, researchers have unveiled compelling evidence supporting the...
Cells are equipped with a remarkable self-cleaning mechanism akin to taking out the trash in a household—a vital process known...
In recent years, the intersection of genetics and oncology has unveiled remarkable possibilities for personalized cancer treatment, transforming the conventional...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine